292 related articles for article (PubMed ID: 18206145)
1. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
4. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
Moradi S; Mollabashi M; Kerman SR
Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
[TBL] [Abstract][Full Text] [Related]
5. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.
Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM
Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
7. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
Bahceci M; Tuzcu A; Canoruc N; Tuzun Y; Kidir V; Aslan C
Horm Res; 2004; 62(6):283-7. PubMed ID: 15542929
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
11. Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?
Huang S; Qiao J; Li R; Wang L; Li M
Fertil Steril; 2010 Jun; 94(1):205-10. PubMed ID: 19368908
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
13. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
14. Lipid and lipoprotein profile in women with polycystic ovary syndrome.
Macut D; Panidis D; Glisić B; Spanos N; Petakov M; Bjekić J; Stanojlović O; Rousso D; Kourtis A; Bozić I; Damjanović S
Can J Physiol Pharmacol; 2008 Apr; 86(4):199-204. PubMed ID: 18418429
[TBL] [Abstract][Full Text] [Related]
15. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
[TBL] [Abstract][Full Text] [Related]
17. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
Kaya C; Pabuccu R; Berker B; Satiroglu H
Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
[TBL] [Abstract][Full Text] [Related]
18. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome.
Ruan X; Dai Y
Med Princ Pract; 2009; 18(2):118-22. PubMed ID: 19204430
[TBL] [Abstract][Full Text] [Related]
19. Increased circulating soluble P-selectin in polycystic ovary syndrome.
Yildiz BO; Bozdag G; Harmanci A; Otegen U; Boynukalin K; Vural Z; Kirazli S; Haznedaroglu IC; Yarali H
Fertil Steril; 2010 May; 93(7):2311-5. PubMed ID: 19261277
[TBL] [Abstract][Full Text] [Related]
20. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]